CI

At a glance

ClinicalIndex Comparison Record
N/ACompleted· 100 enrolled
Drug / intervention
VIP app without HIV-related symptom strategies. +1 morebehavioral
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT03182738
NCT03182738N/ACompleted

Video Information Provider for HIV-Associated Non-AIDS (VIP-HANA) Symptoms

Columbia University·interventional·Posted Jun 9, 2017·Updated Dec 13, 2019

In Brief

A clinical study evaluating VIP app without HIV-related symptom strategies. and VIP app that delivers HIV-related symptom strategies. for HIV (Human Immunodeficiency Virus) and AIDS (Acquired Immunodeficiency Syndrome). Completed, enrolled 100 participants across 1 site.

Detailed Summary

The purpose of this study is to use technology to improve symptom status and ultimately improve patient centered outcomes in people living with HIV/AIDS (PLWHA). The primary purpose of the intervention (VIP-HANA) is to improve symptom status. The investigators hypothesize that VIP-HANA will improve symptom frequency and intensity.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
CountriesUnited States

Timeline

N/ACompletedFinished
2017201820192020202120222023202420252026
First PostedJun 9, 2017
Enrollment StartNov 16, 2016
Primary CompletionApr 3, 2019
Study CompletionMay 31, 2019
TodayJul 2, 2026
Enrollment to primary: 2.4 yearsPosted 9.1 years ago

Interventions

VIP app without HIV-related symptom strategies.behavioral

The control group will receive the VIP app without HIV-related symptom strategies

VIP app that delivers HIV-related symptom strategies.behavioral

The Intervention group will receive the VIP app that delivers HIV-related symptom strategies